Subject category:
Finance, Accounting and Control
Published by:
Harvard Business Publishing
Version: 8 May 2007
Abstract
Conor Medsystems had developed a drug-eluting stent that could capture significant share of the $5 billion global market. Chief Executive Officer, Frank Litvack, is considering alternative sources of financing to test the device.
About
Abstract
Conor Medsystems had developed a drug-eluting stent that could capture significant share of the $5 billion global market. Chief Executive Officer, Frank Litvack, is considering alternative sources of financing to test the device.